Get started
Work

Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline

Year: 2020
Type: article
Abstract: OBJECTIVE: This guideline will provide the practicing endocrinologist with an approach to the assessment and treatment of dyslipidemia in patients with endocrine diseases, with the objective of preventing cardiovascular (CV) events and triglyceride-induced pancreatitis. The guideline reviews data on dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk in patients with endocrine disorders and discusses the evidence for the correction of dyslipidemia by treatment of the endocrine disease. The guideline also addresses whether treatment of the endocrine disease reduces ASCVD risk. CONCLUSION: This guideline focuses on lipid and lipoprotein abnormalities associated with endocrine diseases, including diabetes mellitus, and whether treatment of the endocrine disorder improves not only the lipid abnormalities, but also CV outcomes. Based on the available evidence, recommendations are made for the assessment and management of dyslipidemia in patients with endocrine diseases.
DOI: 10.1210/clinem/dgaa674
Authors: Connie B Newman, Michael J Blaha, Jeffrey B Boord, Bertrand Cariou, Alan Chait, Henry G Fein, Henry N Ginsberg, Ira J Goldberg, M Hassan Murad, Savitha Subramanian, Lisa R Tannock
Institutions: New York University, Johns Hopkins University, Johns Hopkins Hospital, Parkview Health, Centre National de la Recherche Scientifique, Inserm, Centre Hospitalier Universitaire de Nantes, Institut du Thorax, University of Washington, Sinai Hospital, Columbia University, Mayo Clinic, University of Kentucky
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3087299746
FWCI: 14.35
Cites: 539
Cited by: 173
Related to: 10